Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:1053-1054 (24 November), doi:10.1136/bmj.39364.439444.80 (published 24 October 2007)
Women treated for CIN3 should have long term regular screening, even if they are beyond the normal age limit
| The first 150 words of the full text of this article appear below. |
In some countries, such as the United Kingdom, women have long term intensive surveillance after conservative treatment for high grade cervical intraepithelial neoplasia, whereas in others, such as the Netherlands and Finland, they return to regular screening after a few years. The second choice is based on the consistent observation that most recurrences of cervical intraepithelial neoplasia occur in the first two to three years after treatment.1
In this week's BMJ, Strander and colleagues provide strong evidence that women treated for cervical intraepithelial neoplasia grade 3 have a long lasting excess risk of invasive cervical cancer.2 Among more than 130 000 women with this condition, the age adjusted incidence was more than double that of the general population up to 20-25 years after diagnosis. The excess incidence was greater in women treated at older age and in recent years.
How do these findings translate into clinical recommendations? The important
Guglielmo Ronco, responsible for cervical screening evaluation unit1, Mario Giovanni Sideri, director2, Stefano Ciatto, director3
1 Unit of Cancer Epidemiology, Centre for Cancer Prevention, 10123 Torino, Italy, 2 Preventive Gynaecology Unit, European Institute of Oncology, 20141 Milan, Italy, 3 Department of Diagnostic Imaging, Scientific Institute for Cancer Prevention of Tuscany Region, 50131 Florence, Italy
guglielmo.ronco@cpo.it
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+